In fact, TAT-Cx43266–283 importantly reduced not only the number of human glioma cells, but also their expression of nestin, suggesting that the remaining glioma cells did not exhibit stem cell properties known to drive recurrence. This evidence concerns the gene NES and central nervous system cancer.